ClinicalTrials.gg
RecruitingNCT06999850SCTSUpdated Feb 27, 2026

Implementation and Validation of Instrumented Stair Climb Test

An interventional study of Instrumented Stair Climb Test and Walk Test in Stair Climbing, Instrumentation and Test, sponsored by IRCCS Eugenio Medea. Recruiting at 3 sites in Italy. Open to participants aged 4 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-27.

Sponsored by IRCCS Eugenio Medea · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2026, 7 months ago, but the record still lists the study as recruiting.
  • Started Apr 2025; still recruiting 1 year 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Not applicable
Ages
4 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 18 studies in Cerebral Palsy by IRCCS Eugenio Medea — 8 open to participants now, 8 under way, none of them phase 3. Cerebral Palsy · IRCCS Eugenio Medea.

Planned enrollment
2nd of 11
64 · median 44
Started
2025
the only one that year
No phase
11 of 18
6 open now
Registered
17th of 18
by date

Among the 18 studies in Cerebral Palsy by IRCCS Eugenio Medea, this one is the 2nd largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2025, is one of 11 with no phase, and was the 17th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

8 of the 18 studies in Cerebral Palsy by IRCCS Eugenio Medea are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 4 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Cerebral Palsy by IRCCS Eugenio Medea, or all of them as a file.
02

Study summary

The aim of this study is to design an instrumented test for the evaluation of the climb of stairs. In particular, the main purpose is to characterize and compare the performance of subjects, both pediatrics and adults, with different pathologies (cerebral palsy, amputee, Parkinson's disease, stroke and arthroplasty) in carrying out the instrumented test of climbing and descending stairs. This would provide potentially useful information to complement the clinical assessment, including investigating the existence of correlations between the instrumental data obtained and the clinical scales collected. The secondary objective is to evaluate, in a first phase of the study, the feasibility and reliability of the test, analyzing the validity of the indices obtained in terms of intra- and inter-operator reliability on healthy subjects.

Read the detailed description

In today's clinical practice there are several assessment tools available to measure strength, endurance and balance. These tools include manual testing, standardised measurement scales or disease-specific scoring systems in which the results obtained during the performance of different motor tasks are calculated to obtain an overall score reflecting the functional level. Among the most used tests, for example, we remember the Six Minute Walking Test, in which the maximum distance walked, expressed in meters, is measured in a time of 6 minutes under standardized conditions, allowing the evaluation of muscular endurance and gait aspects. In addition to tests that monitor walking abilities, there are tests for more complex activities such as climbing and descending stairs. The ability to climb stairs, in contrast to flat walking, can be considered a more challenging task, as it places greater emphasis on muscle strength of lower limbs, requires a greater range of motion of the lower limb joints and increases the demand for posture control and balance system. In addition, falls from stairs can cause more serious injury or even death than falls on a floor. Therefore, for patients with a higher risk of falling, an objective assessment of the performance of climbing stairs could be of great interest, providing fundamental support in managing the activities of the patient's daily life. In the past, a number of methods and technologies have been proposed to analyse and quantify human gait. Measurement systems range from optoelectronic systems, pressure pads or force plates to mobile sensors worn on the body such as inertial units (IMUs) or pressure pads. Mobile gait analysis systems based on IMU, in particular, are attracting increasing interest for use in long-term assessments that can be easily performed in clinical practice. Similarly, inertial sensors could be adopted for an objective evaluation of the ascent and descent of ladders thanks to adapted step analysis algorithms capable of segmenting, parameterizing and classifying the ascent and descent of ladders. The aim of this study, therefore, is to design a test for the evaluation of climbing stairs based on the use of wearable sensors. In particular, the main objective will be to characterise and compare the performance of subjects with different pathologies, providing potentially useful information to complement clinical evaluation. The secondary objective of the study will be to analyse the reliability of the indices obtained. This work proposal is the result of collaboration between several centres: IRCCS E. Medea, IRCCS Istituti Clinici Maugeri Tradate, Pio Albergo Trivulzio and Politecnico di Milano. In particular, IRCCS E. Medea, IRCCS Istituti Clinici Maugeri Tradate and Pio Albergo Trivulzio will be responsible for the recruitment of subjects and data collection. These centres will have the support of the Politecnico di Milano for the processing of data and for the development of the algorithms necessary for the extraction of the monitored parameters from the devices used.

03

Conditions studied

  • Stair Climbing
  • Instrumentation
  • Test

Keywords

  • Stair Climb Test
  • Cerebral Palsy
  • Stroke
  • amputee
  • Parkinson
04

Who can participate

Ages eligible
4 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Common inclusion criteria for all groups:

- Ability to climb and descend 10 steps with supervision, even with handrail support.

Common exclusion criteria for all groups:

  • Need for help from an operator or use of orthoses to make the stairs;
  • Inability to dress the instrumentation (accelerometer/electromyograph);
  • clinical condition that does not recommend the execution of scales (e.g. Class IV cardiovascular decompensation, epilepsy not controlled by drugs, serious visual disturbances...);
  • inability to follow verbal instructions.

Inclusion criteria for the healthy group :

  • age 4-80 years (8 subjects 4-18 years; 8 subjects 19-65 years; 8 subjects 65-80 years);
  • absence of diagnosis of neurological or orthopaedic pathologies, which impair the patient's mobility.

Inclusion criteria for the PCI group :

  • age range 4-18 years;
  • Diagnosis of Infantile Cerebral Palsy;
  • right or left hemiparesis;
  • ability motor skills in levels I - III according to the GMFCS (Gross Motor Function Classification System).

Inclusion criteria for the Orthopaedic group:

  • Age 65-80 years;
  • postoperative postoperative hip or knee arthroplasty (in election and post-fracture, any revisions will be excluded).

Inclusion criteria for the Amputee group:

  • age range from 19 to 80 years;
  • Leg amputation (trans-tibial), fitted with limb prosthesis.

Inclusion criteria for the Parkinson's group:

  • age range from 65 years;
  • diagnosis of Parkinson's disease or Parkinsonism also on a vascular basis.

Inclusion criteria for the group Ictus Cerebri:

  • Age 65-80 years;
  • Aftereffects of Ictus Cerebri;
  • left or right hemiparesis.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Other
    healthy children

    This group involves healthy children aged 4-18 years old, without gait impairmets

    Other: Walk Test · Other: Repaeted Instrumented Stair Climb Test

  • Other
    Healthy adults

    This group involves healthy adults aged 18-65 years old, without gait impairmets

    Other: Walk Test · Other: Repaeted Instrumented Stair Climb Test

  • Other
    Healthy elderly

    This group involves healthy eleferly aged 65-85 years old, without gait impairmets

    Other: Walk Test · Other: Repaeted Instrumented Stair Climb Test

  • Other
    CP subjects

    pediatric subjects diagnosed with Infantile Cerebral Paralysis (PCI) and clinical sign of left or right hemiparesis;

    Other: Instrumented Stair Climb Test · Other: Walk Test

  • Other
    Leg amputee subjects

    Patients aged 19-80 years, with results of leg amputation (transtibial), who carry limb prostheses

    Other: Instrumented Stair Climb Test · Other: Walk Test

  • Other
    Arthroplasty Subjects

    patients aged 65-80 years, with aftereffects of hip or knee arthroplasty, excluding prosthetic revision procedures

    Other: Instrumented Stair Climb Test · Other: Walk Test

  • Other
    Parkinson Subjects

    atients aged 65-80 years, with diagnosis of Parkinson's disease or Parkinsonism even on a vascular basis

    Other: Instrumented Stair Climb Test · Other: Walk Test

  • Other
    Stroke Subjects

    Patients aged 65-80 years, with aftereffects of Cerebral Stroke with left or right hemiparesis

    Other: Instrumented Stair Climb Test · Other: Walk Test

Interventions

  • OtherInstrumented Stair Climb Test

    Instrumented test of climbing and descending stairs for the evaluation of kinematic and electromyographic variables. The test consists of repeating the ascent and descent of a flight of 10-12 steps;

  • OtherWalk Test

    Assessment of climbing and walking skills through test series: Borg scale: An evaluation scale for measuring effort perception. The evaluation scale consists of answering some questions at the end of the exercise described above; 10-metre walk test (10MWT): Test to assess walking speed in metres per second over a short distance. Can be used to determine functional mobility, gait and vestibular function. The test consists of walking at a steady speed and safely for 10 metres; 30 second sit to stand test: test for the evaluation of strength and endurance of the legs in the elderly. The test consists in performing the movement of standing up and sitting down from a chair for 30 consecutive seconds; Timed Up \& Go test (TUG): test to assess the risk of falling and balance. During the test, patients wear normal footwear and may use a walking aid if necessary. The patient starts in a sitting position, gets up on the therapist's command, walks in a straight line for a distance of 3 m

  • OtherRepaeted Instrumented Stair Climb Test

    Instrumented test of climbing and descending stairs for the evaluation of kinematic and electromyographic variables. The test consists of repeating the ascent and descent of a flight of 10-12 steps. In this case, the ascent and descent of the stairs must be repeated two times. Between the two trial the IMU units must be repositioned.

06

What researchers measure

Primary outcomes

  1. Absolue error automatic test time

    Absolute errors were calculated for the duration time of the stair ascent and descent and for each variable by taking the absolute value after subtracting the values obtained using IMU methods from the value measured using the tradional chronometer method

    Time frame: Through study completion, an average of 1 year

  2. Intra - inter operator variability

    To ensure consistency between the data obtained by the IMU method and the data obtained by the traditional chronometric method, the investigators first calculated the normality of the data. The two-way mixed effects model, absolute agreement, and average measurements were used to calculate the ICCs between the duration time of both systems in case of normality. Instead, the Sperman test was used by the investigator if the data had a non-normal distribution

    Time frame: Through study completion, an average of 1 year

Secondary outcomes

  1. correlations with Ten meters Walk Test (10mWT)

    The investigators determine if there are any correlations between the instrumental data gathered from a test performed using the IMU method and the clinical test of the Ten meters walking test (10mWT). In the 10mWT the total time taken to ambulate 6 meters (m) is recorded to the nearest hundredth of a second. 6 m is then divided by the total time (in seconds) taken to ambulate and recorded in m/s.

    Time frame: Through study completion, an average of 1 year

  2. correlations with 30 seconds chair to stand test

    The investigators determine if there are any correlations between the instrumental data gathered from a test performed using the IMU method and the clinical test of the 30 seconds chair to stand test. The test score is the total number of lifts completed in 30 seconds. During the test, the participant can stop and rest if he is tired without stopping time. If a person fails to perform any high the score for the test is zero

    Time frame: Through study completion, an average of 1 year

  3. correlations with Timed Up and Go (TUG)

    The investigators determine if there are any correlations between the instrumental data gathered from a test performed using the IMU method and the clinical test Timed Up and Go test (TuG). The score in the text corresponds to the time taken by the participants to get up, walk to a distance of 3 m, turn around and return to their seats. Regular walking aids are permitted and recorded if necessary.

    Time frame: Through study completion, an average of 1 year

  4. correlations with Borg Scale

    The investigators determine if there are any correlations between the instrumental data gathered from a test performed using the IMU method and the clinical Borg Scale. This is a scale to assess the intensity of exercise without having to rely on physiological parameters. The original Borg version is a scale of 6-20.

    Time frame: Through study completion, an average of 1 year

07

Study locations

3 of 3 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Apr 2026, 12 months after the start.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 12 months is close to that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
May 22, 2025
First posted
May 31, 2025
StartActual
Apr 4, 2025
Primary completionEst.
Apr 4, 2026
CompletionEst.
Apr 4, 2026
Last update
Feb 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06999850
Collaborators
Politecnico di Milano, ASP Istituti Milanesi Martinitt e Stelline e Pio Albergo Trivulzio, Istituti Clinici Scientifici Maugeri SpA
Responsible party
Sponsor
First posted
May 31, 2025
Start date
Apr 4, 2025
Primary completion
Apr 4, 2026 (estimated)
Completion
Apr 4, 2026 (estimated)
Last update
Feb 27, 2026

Study contacts

Giovanni Pintabona, Medicine
Contact
giovanni.pintabona@lanostrafamiglia.it
+39031877836

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion